New book by Larry Connors Click here Improve your trading - See how
To receive our complimentary newsletters please copy and paste http://www.emergingmarketsllc.com in to your web browser. On the upper right hand corner of the homepage enter your email address and click sign up. You will receive a confirmation email, click the link and your free subscription will be active.
Sciele Pharma, Inc. closed at $30.67 up $11.40 (59.16%) with volume of 28,950,616 Shares of Sciele Pharma Inc. rocketed to their highest level in six years Tuesday after Sciele accepted a buyout offer from Japanese drug maker Shionogi and Co. at a hefty premium. Shionogi agreed Monday to pay $1.4 billion, or $31 per share, for Atlanta-based Sciele. That is a premium of 57.1 percent to Friday's closing price. On Tuesday, Sciele stock jumped $11.41, or 59 percent, to close at $30.68, and earlier set a high of $30.73.
About Sciele Pharma, Inc.
Sciele Pharma, Inc., a pharmaceutical company, engages in the development, marketing, and sale of prescription products. It offers cardiovascular and diabetes products, such as Nitrolingual pump spray to provide acute relief of an attack or prophylaxis of angina pectoris; Sular to treat hypertension; Altoprev to treat hypercholesterolemia and coronary heart diseases; Fortamet, an adjunct to diet and exercise in lowering blood glucose in type 2 diabetes patients; and Triglide, an adjunctive therapy to diet to treat hypercholesterolemia and hypertriglyceridemia. The company also provides women's health products, including Prenate DHA, a prenatal vitamin containing Omega-3 fatty acids; Prenate Elite and OptiNate, which are prenatal vitamins; Zovirax for topical herpes simplex medications; and Ponstel to provide pain relief for primary dysmenorrheal. In addition, it offers pediatrics products, such as Allegra for pediatric allergy and chronic idiopathic urticaria treatment; Methylin to treat attention deficit/hyperactivity disorders; Orapred to provide relief for allergic conditions for patients with asthma; Twinject epinephrine auto-injector to treat allergic reactions and anaphylaxis; and Rondec syrup and oral drops to treat seasonal and perennial allergic rhinitis and vasomotor rhinitis. Further, Sciele offers Zoto HC ear drops to treat swimmers ear infections; Furadantin to provide urinary tract infection relief; Robinal and Robinal Forte, which are used as adjunctive therapy in peptic ulcers; Cognex to treat mild to moderate dementia associated with Alzheimer's disease; Zebutal to treat tension headaches; and Ostiva, which are oral nutritional supplements. It sells its products to pharmaceutical wholesalers, chain drug stores, retail merchandisers, and pharmacies. Sciele Pharma has an agreement with Addrenex Pharmaceuticals, Inc. The company, formerly known as First Horizon Pharmaceutical Corporation, was founded in 1992 and is headquartered in Atlanta, Georgia.
Regions Financial Corporation closed at $11.05 up $1.78 (19.2%) with volume of 36,413,377 Regions Financial Corporation opened the doors yesterday morning to all five former branches of Alpharetta-based Integrity Bank, which closed Friday. Beginning yesterday, these branches will operate under the Regions name, and former customers of Integrity Bank may visit these branches to handle their normal banking transactions. "We're pleased to offer our new customers a safe home and to have them be a part of our continuing growth in the Atlanta area," said Bill Linginfelter, Regions' area executive for Atlanta/North Georgia. "Our new customers can be confident that their money is safe and that they are in good hands. We have bankers at each of these branches to answer any questions and serve their banking needs." About Regions Financial Corporation Regions Financial Corporation operates as the holding company for Regions Bank that provides a range of commercial, retail, and mortgage banking services in the United States. It offers various deposit products, including checking accounts, savings accounts, money market accounts, and foreign deposits, as well as time deposits, including certificates of deposits and individual retirement accounts. The company's loan portfolio comprises commercial loans; real estate mortgage loans; real estate construction loans; home equity loans and lines of credit; indirect lending; and other consumer loans, such as direct consumer installment loans, bankcard, overdrafts and other revolving credit, and educational loans. Regions Financial Corporation, through other subsidiaries, also provides regional brokerage and investment banking products and services, such as securities brokerage, asset management, financial planning, mutual funds, securities underwriting, and sales and trading services, as well as insurance brokerage services for various lines of personal and commercial insurance, including property, casualty, life, health, accident, and credit-related insurance products. In addition, the company factors commercial accounts receivable and performs billing and collection services, focusing on clients in the heavy-duty truck and automotive business, as well as provides domestic and international equipment financing products primarily to commercial clients. As of December 31, 2007, it operated approximately 2,000 banking offices in Alabama, Arkansas, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, Tennessee, Texas, and Virginia. The company was founded in 1970 and is headquartered in Birmingham, Alabama.
PacWest Bancorp closed at $26.46 up $3.78 (16.67%) with volume of 838,054 PacWest Bancorp (Nasdaq: PACW - News) yesterday announced that the private equity firm CapGen Financial has agreed to acquire approximately $100 million of newly issued shares of PacWest Bancorp common stock at a price of $26 per share, representing a 21% premium to the last five trading-day average closing price of PacWest common stock. CapGen will invest in PacWest through an investment vehicle advised by CapGen Capital Advisers LLC. In connection with the investment, the CapGen investment vehicle will seek to register as a bank holding company and, upon consummation of the investment, the CapGen investment vehicle will own approximately 12% of PacWest common stock on a fully-diluted basis as of June 30, 2008.
About PacWest Bancorp
PacWest Bancorp operates as the holding company for Pacific Western Bank that provides banking products and services to small and medium-sized businesses, and individuals in California. It offers savings accounts; business and personal money market and checking accounts; and commercial and consumer banking services, including foreign exchange services. The bank also accepts time and demand deposits, as well as originates various loans, such as secured and unsecured commercial and consumer loans, commercial real estate mortgage loans, SBA loans, and construction loans. In addition, it offers international banking, multi-state deposit, and investment services; and asset-based lending and factoring of accounts receivable to small businesses located in the western United States, as well as issues debit cards, and operates a network of automated teller machines. As of December 31, 2007, the bank operated 60 branch offices located in Los Angeles, Orange, Riverside, San Bernardino, and San Diego Counties, California. The company was founded in 1999. It was formerly known as First Community Bancorp and changed its name to PacWest Bancorp in May 2008. The company is based in San Diego, California.
International Shipholding Corporation closed at $23.73 up $3.48 (17.19%) with volume of 250,554
Privately held Liberty Shipping Group LLC said Tuesday its subsidiary Projection LLC has offered to acquire International Shipholding Corp. in an all-cash deal valued at about $190.2 million. The $25.75-per-share purchase price is a 27 percent premium to International Shipholding's closing stock price on Friday. The company had about 7.4 million shares outstanding as of its last quarterly report on June 30.
About International Shipholding Corporation
International Shipholding Corporation, through its subsidiaries, operates a fleet of U.S. and foreign flag vessels that provide international and domestic maritime transportation services to commercial and governmental customers. It operates in four segments: Time Charter Contracts, Contracts of Affreightment, Rail-Ferry Service, and Other. The Time Charter Contracts segment enables charterer to obtain the right for a specified time period to direct the movements and utilization of the vessel in exchange for payment. This segment includes three RO/RO vessels to the United States Navy's military sealift command; ten pure car/truck carriers; a conveyor-equipped self-unloading coal carrier; two multi-purpose vessels; a tanker; and three container vessels. The Contracts of Affreightment segment offers contracts to provide space on its vessels for the carriage of specified goods or a specified quantity of goods on single voyage or series of voyages. The Rail-Ferry Service segment operates special purpose vessels that carry loaded rail cars between the U.S. Gulf and Mexico. The Other segment provides ship charter brokerage and agency services. As of February 29, 2008, International Shipholding Corporation owned and operated 27 ocean-going vessels and related shoreside handling facilities. The company was founded in 1978 and is headquartered in Mobile, Alabama.
About Emerging Markets Consulting, LLC
Emerging Markets Consulting, LLC is an investor relations and consulting firm serving carefully selected micro cap and small cap clients. Services available include turnkey investor relations services, consulting, marketing and related services needed by publicly traded companies. EMC is unique in that they only work with companies after a stringent due diligence process and they also work with a limited number of clients in order to provide service that is exceptional. The above referenced companies are not clients of Emerging Markets and no compensation has been paid for the exposure provided by this report.
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned. Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.
Please remember to go to www.emergingmarketsllc.com and enter your email address to sign up for our free newsletter.
CONTACT: Emerging Markets Consulting, LLC Tel: +1 321 206 6682 e-mail: jamespainter@emergingmarketsllc.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
